ARTICLE | Clinical News
Prolaris diagnostic data
February 24, 2014 8:00 AM UTC
Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Product: Prolaris Business: Diagnostic Molecular target: NA Description: Molecular diagnostic consisting of a panel of 46 genes involved in ce...